KCT0007601尚未招募未知
A randomized, single-center, double-blinded, a researcher clinical trial to evaluate the effect on gait performance of gait training combined with transcranial direct current stimulation in mild and moderate chronic ischemic stroke
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 90(Year)（—）
- 性别
- All
入选标准
- •1) Patients aged from 20 to 90 years
- •2) 3 months after ischemic stroke onset
- •3) hemiplegic patient
- •4) Functional ambulatory category grade 2~4
- •5) No difficulty in understanding and communicating with physical therapist
- •6) Who voluntarily signed an informed consent form for participation in clinical trial
排除标准
- •1) Who is diagnosed or accompanied with stroke other than ischemic type (e.g. hemorrhagic stroke)
- •2) Who has gait and balance disturbance due to disease other than stroke (e.g. Parkinsonism, neuropathy, myopathy, arthropathy)
- •3) Who has experienced a seizure or get ongoing treatment for epilepsy
- •4) Who received medication, procedure or surgery that may affect gait function in last 1 month
- •5) Who has medical and surgical condition at electrode attachment site
- •6) Unstable vital signs
- •7) Who get ongoing treatment for malignancy
- •8) Who has severe depression and psychiatric disorders that is difficult to adapt the treatment
- •9) Contraindications to electrostimulation
- •(1) Metal in head (except in oral cavity)
- •- cochlear implants, electrode or stimulator, clips or coils for aneurysm, stents, bullet fragments, deep brain stimulator, vagus nerve stimulator, eyeball implant
- •(2) Who has pacemaker, defibrillator, neurostimulator, drug pump, intracardiac injection line
- •(3) Who shows continuos seizure event
- •(4) Who received craniectomy, or ventriculo peritoneal shunt (VP shunt) surgery
- •(5) Who continuously complains of elevated intracranial pressure symptoms such as headache, vomiting or nausea and others
- •10) Who has difficulty in communication due to severe aphasia
- •11) Who has cognitive decline that is difficult to adapt the treatment (Clinical Dementia Rating 1 or more)
- •12) If other treatments that may affect gait function are performed during the study
- •13) Pregnant or breast-feeding woman
- •14) Who are enrolled in other clinical trials
- •15) Who cannot understand the purpose of the clinical trial or perform treatment protocol
- •16) Who is thought to be inappropriate to participate in the clinical trial
研究者
相似试验
尚未招募
Unknown
The effect of gait training combined with transcutaneous electrical nerve stimulation in strokeKCT0008481Chonnam National University Hospital24
已完成
不适用
A single-center, randomized, double-blind, double-dummy, placebo- and active-controlled, 4-way cross-over study to assess next-day driving performance following single and multiple evening administrations of ACT-541468 in middle-aged and elderly subjects.InsomniaNL-OMON48154Idorsia Pharaceuticals Ltd.56
尚未招募
1 期
A Phase I clinical trial to study the effect of two drugs, Insulin Glargine manufactured by BioGenomics limited and Lantus® by comparing pharmacokinetic and pharmacodynamic properties, safety and tolerability in healthy male volunteers.CTRI/2022/09/045313BioGenomics Ltd
招募中
1 期
Phase-I clinical trial of Stelis Insulin Glargine injection 100IU/mL in healthy adultsCTRI/2020/12/030079Stelis Biopharma Pvt Ltd
已完成
不适用
A single-center, randomized, double-blind, two-period cross-over study to investigate the effect of a single intravenous dose of rifampicin on the pharmacokinetics of ACT-246475 in healthy subjects.Acute myocardial infarctionNL-OMON46064Idorsia Pharmaceuticals Ltd14